Published by Benjamin Chiou on 3rd January 2024
(Sharecast News) - C4X Discovery, the AIM-listed drug discovery company, has received a "milestone payment" of $11m from biopharma giant AstraZeneca as part of the progress of its NRF2 Activator programme, causing shares to jump by nearly a half on Wednesday.
URL: http://www.digitallook.com/dl/news/story/34001373/...